Skip to main content
. 2021 Apr 26;146(4):481–488. doi: 10.1159/000515064

Table 1.

Comparison of demographics and underlying cardiovascular comorbidities of patients with COVID-19 admitted to Texas and New York state hospitals

Texas (N = 296, 58%) New York state (N = 218, 42%) p value**
Female, n (%) 165 (56.3) 103 (48.1) 0.068
Age, median (IQR), years 57 (47–66) 63 (51–77) <0.001
Age group, n (%)
 <40 years 49 (16.6) 31 (14.2) <0.001
 40–49 years 46 (15.5) 20 (9.2)
 50–59 years 77 (26.0) 37 (17.0)
 60–69 years 62 (21.0) 48 (22.0)
 70–79 years 42 (14.2) 38 (17.4)
 80+ years 20 (6.8) 44 (20.2)
Race, n (%)
 White 146 (49.3) 156 (71.6) <0.001
 Black 88 (29.7) 24 (11)
 Asian 9 (3.0) 7 (3.2)
 Other 53 (17.9) 31 (14.2)
Hispanic ethnicity, n (%) 127 (43.2) 14 (6.6) <0.001
BMI, median (IQR), kg/m2 30.3 (25.9–35.9) 28.49 (24.5–34.01) 0.015
Insurance, n (%)
 Private 97 (33.0) 50 (23.1) <0.001
 Medicare 65 (22.1) 93 (43.1)
 Medicaid 14 (4.8) 49 (22.7)
 Uninsured 65 (22.1) 3 (1.4)
Positive history of, n (%)
 HTN 174 (58.8) 112 (51.4) 0.095
 HF 31 (10.5) 26 (11.9) 0.604
 CAD 30 (10.1) 41 (18.8) 0.005
 Afib 14 (4.7) 23 (10.6) 0.012
 Stroke 20 (6.8) 21 (9.6) 0.234
 DM 121 (40.9) 66 (30.3) 0.014
 Lung disease 34 (11.5) 33 (15.1) 0.224
 DLD 93 (31.4) 61 (28.0) 0.400
 Cancer 13 (4.4) 19 (8.7) 0.045
 Smoking exposure 87 (33.0) 65 (30.0) 0.481

COVID-19, coronavirus disease 2019; IQR, interquartile range; HTN, hypertension; HF, heart failure; CAD, coronary artery disease; Afib, atrial fibrillation; DM, diabetes mellitus; DLD, dyslipidemia.

**

p values from χ2 tests, except for age and BMI (Mann-Whitney test).